4D Molecular Therapeutics IncNASDAQ:FDMT
- LAST PRICE7.6200
- TODAY'S CHANGE (%)-0.1700 (-2.1823%)
- Bid / Lots7.5200/ 13
- Ask / Lots7.6700/ 2
- Open / Previous Close7.8900 / 7.7900
- Day Range
- 52 Week Range
- Volume921,757
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FDMT |
|---|---|---|
| 09:32 ET | 12760 | 7.95 |
| 09:33 ET | 3240 | 8.0431 |
| 09:35 ET | 3100 | 8.17 |
| 09:37 ET | 9154 | 8.15 |
| 09:39 ET | 3769 | 8.0804 |
| 09:42 ET | 4917 | 8.12 |
| 09:44 ET | 3409 | 8.14 |
| 09:46 ET | 954 | 8.1 |
| 09:48 ET | 1800 | 8.06 |
| 09:50 ET | 11781 | 7.99 |
| 09:51 ET | 2142 | 8.025 |
| 09:53 ET | 3973 | 7.95 |
| 09:55 ET | 1718 | 7.9 |
| 09:57 ET | 183 | 7.895 |
| 10:00 ET | 1000 | 7.9238 |
| 10:02 ET | 440 | 7.9 |
| 10:04 ET | 400 | 7.89 |
| 10:06 ET | 370 | 7.92382 |
| 10:08 ET | 500 | 7.96 |
| 10:09 ET | 771 | 7.96 |
| 10:11 ET | 1350 | 7.95 |
| 10:13 ET | 625 | 7.995 |
| 10:15 ET | 2200 | 7.9936 |
| 10:18 ET | 100 | 8.02 |
| 10:20 ET | 1326 | 8.05 |
| 10:22 ET | 903 | 8.035 |
| 10:24 ET | 400 | 8.01 |
| 10:26 ET | 1100 | 8.02 |
| 10:27 ET | 1227 | 8.04 |
| 10:29 ET | 2380 | 8.05 |
| 10:31 ET | 2700 | 7.995 |
| 10:33 ET | 3028 | 7.97 |
| 10:36 ET | 3001 | 7.97 |
| 10:38 ET | 1600 | 7.98 |
| 10:40 ET | 1351 | 8.0671 |
| 10:42 ET | 1800 | 8 |
| 10:44 ET | 737 | 8 |
| 10:45 ET | 700 | 7.98 |
| 10:47 ET | 1000 | 8.02 |
| 10:49 ET | 4848 | 8.04 |
| 10:51 ET | 2070 | 8.06 |
| 10:54 ET | 600 | 8.04 |
| 10:56 ET | 1800 | 8.055 |
| 10:58 ET | 10699 | 8.0501 |
| 11:00 ET | 1400 | 8.02 |
| 11:02 ET | 2101 | 8 |
| 11:03 ET | 839 | 8 |
| 11:05 ET | 8485 | 8.02 |
| 11:07 ET | 1059 | 7.96 |
| 11:09 ET | 2212 | 7.92 |
| 11:12 ET | 600 | 7.91 |
| 11:14 ET | 1200 | 7.9 |
| 11:16 ET | 900 | 7.91 |
| 11:18 ET | 2700 | 7.925 |
| 11:21 ET | 500 | 7.91 |
| 11:23 ET | 1112 | 7.89 |
| 11:25 ET | 1075 | 7.89 |
| 11:27 ET | 739 | 7.88 |
| 11:30 ET | 900 | 7.885 |
| 11:32 ET | 600 | 7.87 |
| 11:34 ET | 1900 | 7.89 |
| 11:36 ET | 1449 | 7.88 |
| 11:38 ET | 2000 | 7.82 |
| 11:39 ET | 2400 | 7.79 |
| 11:41 ET | 2971 | 7.79 |
| 11:43 ET | 1700 | 7.78 |
| 11:45 ET | 3272 | 7.76 |
| 11:48 ET | 1700 | 7.75 |
| 11:50 ET | 400 | 7.75 |
| 11:52 ET | 700 | 7.74 |
| 11:54 ET | 1700 | 7.76 |
| 11:56 ET | 5669 | 7.795 |
| 11:57 ET | 1000 | 7.825 |
| 11:59 ET | 2050 | 7.84 |
| 12:01 ET | 414 | 7.83 |
| 12:06 ET | 1400 | 7.82 |
| 12:08 ET | 1758 | 7.79 |
| 12:10 ET | 2051 | 7.79 |
| 12:12 ET | 3000 | 7.82 |
| 12:14 ET | 1539 | 7.8 |
| 12:15 ET | 697 | 7.74 |
| 12:17 ET | 600 | 7.76 |
| 12:19 ET | 1300 | 7.76 |
| 12:21 ET | 1830 | 7.75 |
| 12:24 ET | 300 | 7.73 |
| 12:26 ET | 828 | 7.71 |
| 12:28 ET | 2500 | 7.74 |
| 12:30 ET | 1587 | 7.72 |
| 12:32 ET | 900 | 7.7 |
| 12:33 ET | 600 | 7.7 |
| 12:35 ET | 6308 | 7.68 |
| 12:37 ET | 1700 | 7.69 |
| 12:39 ET | 1101 | 7.675 |
| 12:42 ET | 5433 | 7.71 |
| 12:44 ET | 400 | 7.68 |
| 12:46 ET | 800 | 7.66 |
| 12:48 ET | 800 | 7.64 |
| 12:50 ET | 1100 | 7.645 |
| 12:51 ET | 2500 | 7.64 |
| 12:53 ET | 2369 | 7.66 |
| 12:55 ET | 1600 | 7.662 |
| 12:57 ET | 3400 | 7.68 |
| 01:00 ET | 1400 | 7.695 |
| 01:02 ET | 1394 | 7.705 |
| 01:04 ET | 800 | 7.71 |
| 01:06 ET | 1000 | 7.72 |
| 01:08 ET | 800 | 7.69 |
| 01:09 ET | 1050 | 7.69 |
| 01:11 ET | 1906 | 7.72 |
| 01:13 ET | 1226 | 7.71 |
| 01:15 ET | 1500 | 7.74 |
| 01:18 ET | 2354 | 7.68 |
| 01:20 ET | 1300 | 7.65 |
| 01:22 ET | 1241 | 7.65 |
| 01:24 ET | 500 | 7.66 |
| 01:26 ET | 2229 | 7.67 |
| 01:27 ET | 700 | 7.66 |
| 01:29 ET | 5323 | 7.6324 |
| 01:31 ET | 1500 | 7.665 |
| 01:33 ET | 1835 | 7.7073 |
| 01:36 ET | 1524 | 7.66 |
| 01:38 ET | 6435 | 7.64 |
| 01:40 ET | 600 | 7.63 |
| 01:42 ET | 1906 | 7.64 |
| 01:44 ET | 2351 | 7.66 |
| 01:45 ET | 3195 | 7.645 |
| 01:47 ET | 715 | 7.665 |
| 01:49 ET | 1150 | 7.65 |
| 01:51 ET | 5060 | 7.6 |
| 01:54 ET | 3727 | 7.6177 |
| 01:56 ET | 1900 | 7.61 |
| 01:58 ET | 3592 | 7.65 |
| 02:00 ET | 648 | 7.65 |
| 02:02 ET | 1637 | 7.63 |
| 02:03 ET | 700 | 7.64 |
| 02:05 ET | 1061 | 7.62 |
| 02:07 ET | 1843 | 7.63 |
| 02:09 ET | 1700 | 7.68 |
| 02:12 ET | 3150 | 7.6695 |
| 02:14 ET | 1556 | 7.68 |
| 02:16 ET | 614 | 7.67 |
| 02:18 ET | 1760 | 7.64 |
| 02:20 ET | 200 | 7.63 |
| 02:21 ET | 600 | 7.63 |
| 02:23 ET | 561 | 7.62 |
| 02:25 ET | 1213 | 7.61 |
| 02:27 ET | 900 | 7.595 |
| 02:30 ET | 900 | 7.6 |
| 02:32 ET | 2353 | 7.57 |
| 02:34 ET | 2795 | 7.57 |
| 02:36 ET | 600 | 7.58 |
| 02:38 ET | 3226 | 7.565 |
| 02:39 ET | 500 | 7.54 |
| 02:41 ET | 736 | 7.55 |
| 02:43 ET | 1350 | 7.555 |
| 02:45 ET | 2178 | 7.565 |
| 02:48 ET | 3535 | 7.575 |
| 02:50 ET | 2689 | 7.575 |
| 02:52 ET | 2604 | 7.53 |
| 02:54 ET | 972 | 7.54 |
| 02:56 ET | 2748 | 7.55 |
| 02:57 ET | 3205 | 7.57 |
| 02:59 ET | 1100 | 7.57 |
| 03:01 ET | 2767 | 7.59 |
| 03:03 ET | 11485 | 7.57 |
| 03:06 ET | 4343 | 7.56 |
| 03:08 ET | 1727 | 7.61 |
| 03:10 ET | 2732 | 7.57 |
| 03:12 ET | 1946 | 7.58 |
| 03:14 ET | 1100 | 7.58 |
| 03:15 ET | 3151 | 7.59 |
| 03:17 ET | 1800 | 7.6 |
| 03:19 ET | 1346 | 7.59 |
| 03:21 ET | 1700 | 7.6 |
| 03:24 ET | 2300 | 7.58 |
| 03:26 ET | 5765 | 7.57 |
| 03:28 ET | 1401 | 7.56 |
| 03:30 ET | 3900 | 7.58 |
| 03:32 ET | 3594 | 7.6 |
| 03:33 ET | 3543 | 7.6 |
| 03:35 ET | 5526 | 7.56 |
| 03:37 ET | 7540 | 7.52 |
| 03:39 ET | 2200 | 7.525 |
| 03:42 ET | 2259 | 7.52 |
| 03:44 ET | 1859 | 7.53 |
| 03:46 ET | 5712 | 7.54 |
| 03:48 ET | 8074 | 7.58 |
| 03:50 ET | 4195 | 7.56 |
| 03:51 ET | 4007 | 7.57 |
| 03:53 ET | 17161 | 7.59 |
| 03:55 ET | 15015 | 7.59 |
| 03:57 ET | 11421 | 7.605 |
| 04:00 ET | 196647 | 7.62 |
Nov 21, 2024
DJ 4D Molecular Therapeutics Initiated at Underweight by Morgan Stanley, from 6:34AM ET on Thursday Nov 21, 2024 by Dow Jones
6:34AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 14, 2024
DJ 4D Molecular Therapeutics Is Maintained at Buy by Chardan Capital, from 4:54PM ET on Thursday Nov 14, 2024 by Dow Jones
4:54PM ET on Thursday Nov 14, 2024 by Dow JonesDJ 4D Molecular Therapeutics Price Target Maintained With a $36.00/Share by HC Wainwright & Co., from 1:41PM ET on Thursday Nov 14, 2024 by Dow Jones
1:41PM ET on Thursday Nov 14, 2024 by Dow JonesDJ 4D Molecular Therapeutics Is Maintained at Outperform by RBC Capital, from 12:04PM ET on Thursday Nov 14, 2024 by Dow Jones
12:04PM ET on Thursday Nov 14, 2024 by Dow Jones4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV, from 8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
8:00AM ET on Thursday Nov 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
4D Molecular Therapeutics Inc | 404.8M | -2.8x | --- |
AC Immune SA | 334.4M | -7.5x | --- |
Verve Therapeutics Inc | 410.6M | -2.1x | --- |
ProQR Therapeutics NV | 383.4M | -11.6x | --- |
MeiraGTx Holdings PLC | 457.7M | -4.9x | --- |
Cartesian Therapeutics Inc | 479.6M | -0.5x | --- |
Company Information
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidates, with five product candidates in clinical trials in seven patient populations: 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), 4D-710 for the treatment of cystic fibrosis lung disease (both in modulator ineligible and eligible populations), 4D-310 for the treatment of Fabry disease cardiomyopathy, 4D-125 for the treatment of X-linked retinitis pigmentosa (XLRP), and 4D-110 for the treatment of choroideremia. In addition, it has two product candidates in preclinical development: 4D-175 for geographic atrophy (GA) and 4D-725 for alpha-1 antitrypsin deficiency lung disease.
Contact Information
- Headquarters
- 5858 Horton Street #455, EmeryvilleEMERYVILLE, CA, United States 94608
- Phone
- 510-505-2680
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- John Milligan
- President, Chief Operating Officer
- Fariborz Kamal
- Chief Executive Officer, Co-Founder, Director
- David Kirn
- Chief Financial and Business Officer
- Uneek Mehra
- Chief Medical Officer
- Robert Kim
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $404.8M |
|---|---|
Revenue (TTM) | $18.0K |
Shares Outstanding | 52.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.76 |
EPS | $-2.76 |
Book Value | $7.15 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 22,491.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -935,416.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
